Citius Pharmaceuticals マネジメント
マネジメント 基準チェック /24
Citius Pharmaceuticalsの CEO はLeonard Mazurで、 Mar2016年に任命され、 の在任期間は 8.67年です。 の年間総報酬は$ 1.98Mで、 24%給与と76%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の5.67%を直接所有しており、その価値は$ 3.92M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と8.5年です。
主要情報
Leonard Mazur
最高経営責任者
US$2.0m
報酬総額
| CEO給与比率 | 24.0% |
| CEO在任期間 | 8.7yrs |
| CEOの所有権 | 5.7% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 8.5yrs |
経営陣の近況
Recent updates
We Think Citius Pharmaceuticals (NASDAQ:CTXR) Needs To Drive Business Growth Carefully
Apr 06
We're Keeping An Eye On Citius Pharmaceuticals' (NASDAQ:CTXR) Cash Burn Rate
Dec 08Will Citius Pharmaceuticals (NASDAQ:CTXR) Spend Its Cash Wisely?
Aug 01We Think Citius Pharmaceuticals (NASDAQ:CTXR) Can Afford To Drive Business Growth
Apr 12Here's Why We're Watching Citius Pharmaceuticals' (NASDAQ:CTXR) Cash Burn Situation
Dec 25Citius Pharma submits biologics license application to FDA for immunotherapy I/ONTAK
Sep 28Citius Pharmaceuticals GAAP EPS of -$0.06
Aug 11Here's Why Citius Pharmaceuticals (NASDAQ:CTXR) Must Use Its Cash Wisely
Aug 05Citius holds pre-biologics license application meeting with FDA for immunotherapy I/ONTAK
Jul 12Citius Pharmaceuticals: Hoping For A Turnaround Strategy
Jul 05Critical Care Biopharma - Citius Pharmaceuticals
Apr 13Citius: 2022 Is A Year Of Catalysts
Mar 28We Think Citius Pharmaceuticals (NASDAQ:CTXR) Can Afford To Drive Business Growth
Dec 04Citius Pharmaceuticals, Inc.: Burning Cash Before Commercialization
Sep 26Companies Like Citius Pharmaceuticals (NASDAQ:CTXR) Are In A Position To Invest In Growth
Aug 28Citius: Halt For Superiority On The Horizon
Jun 15We Think Citius Pharmaceuticals (NASDAQ:CTXR) Can Afford To Drive Business Growth
May 15Citius Pharmaceuticals shares rise in anticipation of Mino-Lok phase 3 results
Apr 26Is Citius Pharmaceuticals (NASDAQ:CTXR) In A Good Position To Deliver On Growth Plans?
Dec 18CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$40m |
| Mar 31 2024 | n/a | n/a | -US$37m |
| Dec 31 2023 | n/a | n/a | -US$39m |
| Sep 30 2023 | US$2m | US$475k | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$31m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | n/a | n/a | -US$28m |
| Sep 30 2022 | US$1m | US$400k | -US$34m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | n/a | n/a | -US$26m |
| Sep 30 2021 | US$788k | US$348k | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$24m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | n/a | n/a | -US$21m |
| Sep 30 2020 | US$550k | US$250k | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | n/a | n/a | -US$16m |
| Sep 30 2019 | US$473k | US$250k | -US$16m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | n/a | n/a | -US$13m |
| Sep 30 2018 | US$398k | US$250k | -US$13m |
報酬と市場: Leonardの 総報酬 ($USD 1.98M ) は、 US市場 ($USD 651.15K ) の同規模の企業の平均を上回っています。
報酬と収益: Leonardの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Leonard Mazur (79 yo)
8.7yrs
在職期間
US$1,981,113
報酬
Mr. Leonard L. Mazur is Chairman, Chief Executive Officer & President of Citius Oncology, Inc. from August 12, 2024. Mr. Mazur has been Chief Executive Officer of Citius Pharmaceuticals, Inc. since May 01,...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 8.7yrs | US$1.98m | 5.67% $ 3.9m | |
| Co-Founder & Executive Vice Chairman | 9.1yrs | US$1.59m | 1.1% $ 761.4k | |
| Executive VP & Chief Medical Officer | 4.3yrs | US$1.17m | 0% $ 0 | |
| Chief Business Officer | 7yrs | US$809.00k | 0.033% $ 23.1k | |
| Executive Vice President of Operations | 8.7yrs | データなし | データなし | |
| Vice President of Investor Relations & Corporate Communications | no data | データなし | データなし | |
| Senior VP and Head of Clinical Operations & Quality Assurance | 2.8yrs | データなし | データなし | |
| Senior Vice President of Business Strategy | 3.8yrs | データなし | データなし | |
| Executive Vice President of Chemistry | 3yrs | データなし | データなし | |
| Executive Vice President of Quality Assurance | 1.8yrs | データなし | データなし | |
| Executive Vice President of Regulatory Affairs | 1.2yrs | データなし | データなし |
3.8yrs
平均在職期間
69.5yo
平均年齢
経験豊富な経営陣: CTXRの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 10.2yrs | US$1.98m | 5.67% $ 3.9m | |
| Co-Founder & Executive Vice Chairman | 9.1yrs | US$1.59m | 1.1% $ 761.4k | |
| Independent Director | 1.8yrs | US$150.13k | 0% $ 0 | |
| ARDS Scientific Advisory Board Member | no data | データなし | データなし | |
| Independent Director | 9.1yrs | US$196.97k | 0% $ 0 | |
| Independent Director | 8.7yrs | US$190.97k | 0.0066% $ 4.5k | |
| Independent Director | 8.4yrs | US$190.97k | 0.0013% $ 904.9 | |
| Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | 6.3yrs | データなし | データなし | |
| ARDS Scientific Advisory Board Member | 3.4yrs | データなし | データなし | |
| ARDS Scientific Advisory Board Member | no data | データなし | データなし |
8.5yrs
平均在職期間
77yo
平均年齢
経験豊富なボード: CTXRの 取締役会 は 経験豊富 であると考えられます ( 8.5年の平均在任期間)。